Skip to main content
C. David Hansen
( out of 831 reviews )

C. David Hansen, MD

Languages spoken: English, German

Clinical Locations

Midvalley Health Center Dermatology

Dermatology
Murray
801-581-2955
  • C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

    Board Certification

    American Board of Dermatology (Dermatology)

    Patient Rating

    5.0 /5
    ( out of 831 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 15, 2025
    MIDVALLEY

    Thank you for your service'.

    January 14, 2025
    MIDVALLEY

    He's a dermatological rock star.

    January 09, 2025
    MIDVALLEY

    He's the best dermatologist ever he's caring kind treat you like family. I'm sad to see him leave if and when he leaves.

    January 07, 2025
    MIDVALLEY

    Dr. Hansen has always been friendly and kind. He provides wonderful service and breaks the tension from the fear of the possibilities of skin conditions. I have gone to help a couple of times over skin conditions, and he always helped eased the fear of it being cancerous. He also provides quick but efficient service. I don't feel rushed or "just another number" when I am his patient.

    January 01, 2025
    MIDVALLEY

    Great ! Thx !

    December 31, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr Hansen is the best!!

    December 25, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen has always left us with what appears to be exceptional care and efficient implementation of necessary care. We always appreciate his capability.

    December 20, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I always receive the best care

    December 10, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    There's NO ONE better for my care than Dr. Hansen!!!! He is THE BEST!!!! His attention to detail, great personality and concern for my health is INCREDIBLE!!! Don't ever lose him!!!!

  • C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

    Board Certification and Academic Information

    Academic Departments Dermatology -Professor (Clinical)
    Board Certification
    American Board of Dermatology (Dermatology)

    Education history

    Postdoctoral Training Dermatology - Massachusetts General Hospital Postdoctoral Training
    Residency Dermatology - University of Michigan Resident
    Internship University of Iowa Hospitals and Clinics Intern
    Professional Medical Medicine - University of Utah Hospital School of Medicine M.D.
    Undergraduate Chemistry - University of Utah B.S.
    Undergraduate Chemistry - University of Utah

    Selected Publications

    Journal Article

    1. Schwartz JN, Evans HA, Otoole EA, Hansen CD (2023). Pachyonychia Congenita Project: Advancing Research and Drug Development through Collaboration. Keio J Med. (Read full article)
    2. Lipner SR, Falotico JM, Matushansky JT, Evans H, Schwartz J, Hansen CD (2022). Walking a day in a pachyonychia congenita patient's shoes: Impact on plantar pain and activity levels measured with wristband activity trackers. Indian J Dermatol Venereol Leprol, 89(6), 850-853. (Read full article)
    3. Tan XL, Thomas BR, Steele L, Schwartz J, Hansen CD, OToole EA (2022). Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study. J Am Acad Dermatol. (Read full article)
    4. Mathews J, Hansen CD, Chandrashekar L (2020). Homozygous dominant missense mutation in Keratin 6b leading to severe pachyonychia congenita. Clin Exp Dermatol, 46(2), 410-412. (Read full article)
    5. Samuelov L, Sarig O, Adir N, Pavlovsky M, Smith FJ, Schwartz J, Hansen CD, Sprecher E (2021). Identification of clinically useful predictive genetic variants in pachyonychia congenita. Clin Exp Dermatol, 46, 867-873. (Read full article)
    6. Stewart CL, Takeshita J, Hansen CD, Rubin AI (2020). The histopathological features of the nail plate in pachyonychia congenita. J Cutan Pathol, 47(4), 357-362. (Read full article)
    7. Goldberg I, Mashiah J, Kutz A, Derowe A, Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD (2019). Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children. Br J Dermatol, 182(3), 708-713. (Read full article)
    8. Samuelov L, Smith FJD, Hansen CD, Sprecher E (2020). Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol, 182(3), 738-746. (Read full article)
    9. Han M, Wald I, Usher W, Wu Q, Wang F, Pascucci V, Hansen CD, Johnson CR (2019). Ray Tracing Generalized Tube Primitives: Method and Applications. Eurographics Workshop Vis Comput Biomed, 38(3), 467-478. (Read full article)
    10. Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD (2012). A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol, 67(4), 680-6. (Read full article)
    11. Wilson NJ, Leachman SA, Hansen CD, McMullan AC, Milstone LM, Schwartz ME, McLean WH, Hull PR, Smith FJ (2011). A large mutational study in pachyonychia congenita. J Invest Dermatol, 131(5), 1018-24. (Read full article)
    12. Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, Hansen CD, Eliason MJ, Srivatsa GS, Kornbrust DJ, Smith FJ, McLean WI, Milstone LM, Kaspar RL (2010). First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther, 18(2), 442-6. (Read full article)
    13. Hansen CD (1994). Advances in the Treatment of Onychomycosis. 1-3.

    Letter

    1. Steele L, Schwartz J, Hansen CD, OToole EA (2022). Prevalence and Characterization of Itch in Pachyonychia Congenita. [Letter to the editor]. JAMA Dermatol, 157(11), 1378-1380. (Read full article)
    2. Funk T, Hansen CD, Paller A, OToole EA (2019). Update on pachyonychia congenita research. [Letter to the editor]. Br J Dermatol, 182(3), 788-789. (Read full article)
    3. Wilson NJ, Prez ML, Vahlquist A, Schwartz ME, Hansen CD, McLean WH, Smith FJ (2012). Homozygous dominant missense mutation in keratin 17 leads to alopecia in addition to severe pachyonychia congenita. [Letter to the editor]. J Invest Dermatol, 132(7), 1921-4. (Read full article)